Similarly to cerebellar progenitors, the pharmacological inhibition of ERAP1 impaired both tumor cell proliferation in a dose- and time-dependent manner (Fig. 5g) and clonogenic self-renewal ability (Fig. 5h). This evidence concerns the gene ERAP1 and neoplasm.